Bionano Genomics (BNGO) Net Cash Flow Growth (3y) (2020 - 2026)
Bionano Genomics (BNGO) Net Cash Flow Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -16.59% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 65.71% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 1.60% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -339.28% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 2.16% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -242.00% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 78.59% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 36.96% |
| 10 | Bionano Genomics | 13.74 Mn | 3.81 Mn | 4.31 Mn | -27.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -27.34% |
| Mar 31, 2026 | 33.97% |
| Dec 31, 2025 | 27.34% |
| Sep 30, 2025 | -34.86% |
| Jun 30, 2025 | -26.25% |
| Mar 31, 2025 | -124.77% |
| Dec 31, 2024 | 26.06% |
| Sep 30, 2024 | 59.58% |
| Jun 30, 2024 | 29.91% |
| Mar 31, 2024 | -26.13% |
| Dec 31, 2023 | -41.80% |
| Sep 30, 2023 | 127.59% |
| Jun 30, 2023 | 5.94% |
| Mar 31, 2023 | 51.86% |
| Dec 31, 2022 | -65.06% |
| Sep 30, 2022 | 29.27% |
| Jun 30, 2022 | 36.83% |
| Mar 31, 2022 | -28.49% |
| Dec 31, 2021 | -204.01% |
| Sep 30, 2021 | -155.70% |